Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.
Identifieur interne : 001E85 ( PubMed/Corpus ); précédent : 001E84; suivant : 001E86Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.
Auteurs : Katsumi Ikeda ; Yoshinari Ogawa ; Hisateru Komatsu ; Yoshihiro Mori ; Akira Ishikawa ; Takayoshi Nakajima ; Gou Oohira ; Shinya Tokunaga ; Hiroko Fukushima ; Takeshi InoueSource :
- World journal of surgical oncology [ 1477-7819 ] ; 2012.
English descriptors
- KwdEn :
- Arm (pathology), Arm (surgery), Axilla, Breast Neoplasms (pathology), Breast Neoplasms (surgery), Carcinoma, Ductal, Breast (secondary), Carcinoma, Ductal, Breast (surgery), Carcinoma, Lobular (secondary), Carcinoma, Lobular (surgery), Female, Humans, Lymph Nodes (pathology), Lymph Nodes (surgery), Lymphatic Metastasis, Lymphatic Vessels (pathology), Lymphatic Vessels (surgery), Lymphedema (etiology), Lymphedema (prevention & control), Middle Aged, Neoplasm Staging, Prognosis, Sentinel Lymph Node Biopsy (adverse effects).
- MESH :
- adverse effects : Sentinel Lymph Node Biopsy.
- etiology : Lymphedema.
- pathology : Arm, Breast Neoplasms, Lymph Nodes, Lymphatic Vessels.
- prevention & control : Lymphedema.
- secondary : Carcinoma, Ductal, Breast, Carcinoma, Lobular.
- surgery : Arm, Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Lymph Nodes, Lymphatic Vessels.
- Axilla, Female, Humans, Lymphatic Metastasis, Middle Aged, Neoplasm Staging, Prognosis.
Abstract
Axillary reverse mapping (ARM) is a new technique to preserve upper extremity lymphatic pathways during axillary lymph node dissection (ALND), thereby preventing lymphedema patients with breast cancer. However, the oncologic safety of sparing the nodes identified by ARM (ARM nodes), some of which are positive, has not been verified. We evaluated the metastatic status of ARM nodes and the efficacy of fine needle aspiration cytology (FNAC) in assessing ARM node metastasis.
DOI: 10.1186/1477-7819-10-233
PubMed: 23116152
Links to Exploration step
pubmed:23116152Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.</title><author><name sortKey="Ikeda, Katsumi" sort="Ikeda, Katsumi" uniqKey="Ikeda K" first="Katsumi" last="Ikeda">Katsumi Ikeda</name><affiliation><nlm:affiliation>Department of Breast Surgical Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan. bfaqt406@cwo.zaq.ne.jp</nlm:affiliation></affiliation></author><author><name sortKey="Ogawa, Yoshinari" sort="Ogawa, Yoshinari" uniqKey="Ogawa Y" first="Yoshinari" last="Ogawa">Yoshinari Ogawa</name></author><author><name sortKey="Komatsu, Hisateru" sort="Komatsu, Hisateru" uniqKey="Komatsu H" first="Hisateru" last="Komatsu">Hisateru Komatsu</name></author><author><name sortKey="Mori, Yoshihiro" sort="Mori, Yoshihiro" uniqKey="Mori Y" first="Yoshihiro" last="Mori">Yoshihiro Mori</name></author><author><name sortKey="Ishikawa, Akira" sort="Ishikawa, Akira" uniqKey="Ishikawa A" first="Akira" last="Ishikawa">Akira Ishikawa</name></author><author><name sortKey="Nakajima, Takayoshi" sort="Nakajima, Takayoshi" uniqKey="Nakajima T" first="Takayoshi" last="Nakajima">Takayoshi Nakajima</name></author><author><name sortKey="Oohira, Gou" sort="Oohira, Gou" uniqKey="Oohira G" first="Gou" last="Oohira">Gou Oohira</name></author><author><name sortKey="Tokunaga, Shinya" sort="Tokunaga, Shinya" uniqKey="Tokunaga S" first="Shinya" last="Tokunaga">Shinya Tokunaga</name></author><author><name sortKey="Fukushima, Hiroko" sort="Fukushima, Hiroko" uniqKey="Fukushima H" first="Hiroko" last="Fukushima">Hiroko Fukushima</name></author><author><name sortKey="Inoue, Takeshi" sort="Inoue, Takeshi" uniqKey="Inoue T" first="Takeshi" last="Inoue">Takeshi Inoue</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23116152</idno><idno type="pmid">23116152</idno><idno type="doi">10.1186/1477-7819-10-233</idno><idno type="wicri:Area/PubMed/Corpus">001E85</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E85</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.</title><author><name sortKey="Ikeda, Katsumi" sort="Ikeda, Katsumi" uniqKey="Ikeda K" first="Katsumi" last="Ikeda">Katsumi Ikeda</name><affiliation><nlm:affiliation>Department of Breast Surgical Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan. bfaqt406@cwo.zaq.ne.jp</nlm:affiliation></affiliation></author><author><name sortKey="Ogawa, Yoshinari" sort="Ogawa, Yoshinari" uniqKey="Ogawa Y" first="Yoshinari" last="Ogawa">Yoshinari Ogawa</name></author><author><name sortKey="Komatsu, Hisateru" sort="Komatsu, Hisateru" uniqKey="Komatsu H" first="Hisateru" last="Komatsu">Hisateru Komatsu</name></author><author><name sortKey="Mori, Yoshihiro" sort="Mori, Yoshihiro" uniqKey="Mori Y" first="Yoshihiro" last="Mori">Yoshihiro Mori</name></author><author><name sortKey="Ishikawa, Akira" sort="Ishikawa, Akira" uniqKey="Ishikawa A" first="Akira" last="Ishikawa">Akira Ishikawa</name></author><author><name sortKey="Nakajima, Takayoshi" sort="Nakajima, Takayoshi" uniqKey="Nakajima T" first="Takayoshi" last="Nakajima">Takayoshi Nakajima</name></author><author><name sortKey="Oohira, Gou" sort="Oohira, Gou" uniqKey="Oohira G" first="Gou" last="Oohira">Gou Oohira</name></author><author><name sortKey="Tokunaga, Shinya" sort="Tokunaga, Shinya" uniqKey="Tokunaga S" first="Shinya" last="Tokunaga">Shinya Tokunaga</name></author><author><name sortKey="Fukushima, Hiroko" sort="Fukushima, Hiroko" uniqKey="Fukushima H" first="Hiroko" last="Fukushima">Hiroko Fukushima</name></author><author><name sortKey="Inoue, Takeshi" sort="Inoue, Takeshi" uniqKey="Inoue T" first="Takeshi" last="Inoue">Takeshi Inoue</name></author></analytic><series><title level="j">World journal of surgical oncology</title><idno type="eISSN">1477-7819</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Arm (pathology)</term><term>Arm (surgery)</term><term>Axilla</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Carcinoma, Ductal, Breast (secondary)</term><term>Carcinoma, Ductal, Breast (surgery)</term><term>Carcinoma, Lobular (secondary)</term><term>Carcinoma, Lobular (surgery)</term><term>Female</term><term>Humans</term><term>Lymph Nodes (pathology)</term><term>Lymph Nodes (surgery)</term><term>Lymphatic Metastasis</term><term>Lymphatic Vessels (pathology)</term><term>Lymphatic Vessels (surgery)</term><term>Lymphedema (etiology)</term><term>Lymphedema (prevention & control)</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Sentinel Lymph Node Biopsy (adverse effects)</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arm</term><term>Breast Neoplasms</term><term>Lymph Nodes</term><term>Lymphatic Vessels</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Carcinoma, Ductal, Breast</term><term>Carcinoma, Lobular</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Arm</term><term>Breast Neoplasms</term><term>Carcinoma, Ductal, Breast</term><term>Carcinoma, Lobular</term><term>Lymph Nodes</term><term>Lymphatic Vessels</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Axilla</term><term>Female</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Axillary reverse mapping (ARM) is a new technique to preserve upper extremity lymphatic pathways during axillary lymph node dissection (ALND), thereby preventing lymphedema patients with breast cancer. However, the oncologic safety of sparing the nodes identified by ARM (ARM nodes), some of which are positive, has not been verified. We evaluated the metastatic status of ARM nodes and the efficacy of fine needle aspiration cytology (FNAC) in assessing ARM node metastasis.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23116152</PMID><DateCreated><Year>2012</Year><Month>12</Month><Day>21</Day></DateCreated><DateCompleted><Year>2013</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-7819</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2012</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>World journal of surgical oncology</Title><ISOAbbreviation>World J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.</ArticleTitle><Pagination><MedlinePgn>233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1477-7819-10-233</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Axillary reverse mapping (ARM) is a new technique to preserve upper extremity lymphatic pathways during axillary lymph node dissection (ALND), thereby preventing lymphedema patients with breast cancer. However, the oncologic safety of sparing the nodes identified by ARM (ARM nodes), some of which are positive, has not been verified. We evaluated the metastatic status of ARM nodes and the efficacy of fine needle aspiration cytology (FNAC) in assessing ARM node metastasis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixty patients with breast cancer who underwent ARM during ALND between January 2010 and July 2012 were included in this study. Twenty-five patients were clinically node-positive and underwent ALND without sentinel lymph node biopsy (SLNB). Thirty-five patients were clinically node-negative but sentinel node-positive on the SLND. The lymphatic pathway was visualized using fluorescence imaging with indocyanine green. ARM nodes in ALND field, whose status was diagnosed using FNAC, were removed and processed for histology. We evaluated the correlation between the cytological findings of FNAC and the histological analysis of excised ARM nodes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean number of ARM nodes identified per patient was 1.6 ±0.9 in both groups. In most patients without (88%) and with (79%) SLNB, the ARM nodes were located between the axillary vein and the second intercostobrachial nerve. FNAC was performed for 45 ARM nodes, 10 of which could not be diagnosed. Six of the patients without SLNB (24%) and onewith SLNB (3%) had positive ARM nodes. Of these sevenpatients, four had >3 positive ARM nodes. There was no discordance between the cytological and histological diagnosis of ARM nodes status.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Positive ARM nodes were observed in the patients not only with extensive nodal metastasis but also in those with a few positive nodes. FNAC for ARM nodes was helpful in assessing ARM nodes metastasis, which can be beneficial in sparing nodes essential for lymphatic drainage, thereby potentially reducing the incidence of lymphedema. However, the success of sampling rates needs to be improved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Katsumi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Breast Surgical Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan. bfaqt406@cwo.zaq.ne.jp</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Yoshinari</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Komatsu</LastName><ForeName>Hisateru</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Akira</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Nakajima</LastName><ForeName>Takayoshi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Oohira</LastName><ForeName>Gou</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Tokunaga</LastName><ForeName>Shinya</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Fukushima</LastName><ForeName>Hiroko</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Studies</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>World J Surg Oncol</MedlineTA><NlmUniqueID>101170544</NlmUniqueID><ISSNLinking>1477-7819</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2776-81</RefSource><PMID Version="1">9874397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2007 Sep;14(9):2490-6</RefSource><PMID Version="1">17549570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2005 Dec 17;366(9503):2087-106</RefSource><PMID Version="1">16360786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2007 Jun;14(6):1890-5</RefSource><PMID Version="1">17479341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Breast Cancer. 2012 Mar;15(1):91-7</RefSource><PMID Version="1">22493634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2011 Mar;5(1):62-72</RefSource><PMID Version="1">20972640</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2002 Sep 1;95(5):982-8</RefSource><PMID Version="1">12209680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer. 2011 Jul;18(3):174-80</RefSource><PMID Version="1">21331463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Sep;16(9):2459-63</RefSource><PMID Version="1">19506954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Surg. 2008 May;206(5):1038-42; discussion 1042-4</RefSource><PMID Version="1">18471751</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2011 Feb 9;305(6):569-75</RefSource><PMID Version="1">21304082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2007 May;103(1):85-91</RefSource><PMID Version="1">17033920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2008 Sep;15(9):2550-5</RefSource><PMID Version="1">18618185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2010 Mar 1;101(3):217-21</RefSource><PMID Version="1">20063370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AJR Am J Roentgenol. 2006 May;186(5):1342-8</RefSource><PMID Version="1">16632729</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Sep 15;92(6):1368-77</RefSource><PMID Version="1">11745212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Jun 1;116(11):2543-8</RefSource><PMID Version="1">20336790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Feb;119(3):529-35</RefSource><PMID Version="1">19842033</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018270" MajorTopicYN="N">Carcinoma, Ductal, Breast</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018275" MajorTopicYN="N">Carcinoma, Lobular</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042601" MajorTopicYN="N">Lymphatic Vessels</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3527301</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23116152</ArticleId><ArticleId IdType="pii">1477-7819-10-233</ArticleId><ArticleId IdType="doi">10.1186/1477-7819-10-233</ArticleId><ArticleId IdType="pmc">PMC3527301</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E85 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001E85 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23116152
|texte= Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23116152" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |